BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 25317653)

  • 1. Retinoblastoma in Jordan, 2003-2013: ocular survival and associated factors.
    Al-Nawaiseh I; Jammal HM; Khader YS; Jaradat I; Barham R
    Ophthalmic Epidemiol; 2014 Dec; 21(6):406-11. PubMed ID: 25317653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.
    Naseripour M; Nazari H; Bakhtiari P; Modarres-zadeh M; Vosough P; Ausari M
    Br J Ophthalmol; 2009 Jan; 93(1):28-32. PubMed ID: 18952647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course of retinoblastoma.
    Islam F; Zafar SN; Siddiqui SN; Khan A
    J Coll Physicians Surg Pak; 2013 Aug; 23(8):566-9. PubMed ID: 23930873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoreduction for unilateral retinoblastoma.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
    Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
    Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH
    JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socioeconomic and psychological impact of treatment for unilateral intraocular retinoblastoma.
    Soliman SE; Dimaras H; Souka AA; Ashry MH; Gallie BL
    J Fr Ophtalmol; 2015 Jun; 38(6):550-8. PubMed ID: 25982424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
    Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Mäusert J; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Lohmann DR; Jöckel KH
    J Clin Oncol; 2016 Sep; 34(26):3183-8. PubMed ID: 27382102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.
    Berry JL; Jubran R; Kim JW; Wong K; Bababeygy SR; Almarzouki H; Lee TC; Murphree AL
    Pediatr Blood Cancer; 2013 Apr; 60(4):688-93. PubMed ID: 22997170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eye-Preserving Therapies for Advanced Retinoblastoma: A Multicenter Cohort of 1678 Patients in China.
    Zhou C; Wen X; Ding Y; Ding J; Jin M; Liu Z; Wang S; Han M; Yuan H; Xiao Y; Wu L; Wang J; Li Y; Yu J; Wen Y; Ye J; Liu R; Chen Z; Xue S; Lu W; Liao H; Cui J; Zhu D; Lu F; Tang S; Wu Y; Yangkyi T; Zhang G; Wubuli M; Guo H; Wang X; He Y; Sheng X; Wang Q; Luo Y; Fan J; Qi J; Yu Z; Tan J; Liang J; Sun X; Jin L; Yang X; Zhang J; Ji X; Zhao J; Jia R; Fan X
    Ophthalmology; 2022 Feb; 129(2):209-219. PubMed ID: 34536465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina.
    Chantada GL; Fandiño AC; Schvartzman E; Raslawski E; Schaiquevich P; Manzitti J
    Pediatr Blood Cancer; 2014 May; 61(5):821-6. PubMed ID: 24243706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoblastoma in Turkey: results from a tertiary care center in Ankara.
    Gündüz K; Köse K; Kurt RA; Süren E; Taçyildiz N; Dinçaslan H; Ünal E; Erden E; Heper AO
    J Pediatr Ophthalmol Strabismus; 2013; 50(5):296-303. PubMed ID: 23937863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments.
    Venturi C; Bracco S; Cerase A; Cioni S; Galluzzi P; Gennari P; Vallone IM; Tinturini R; Vittori C; De Francesco S; Caini M; D'Ambrosio A; Toti P; Renieri A; Hadjistilianou T
    Acta Ophthalmol; 2013 Jun; 91(4):335-42. PubMed ID: 22268993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enucleation for retinoblastoma: the experience of a single center in Jordan.
    Sultan I; Wilson MW; Nawaiseh I; Mehyar M; Kharma S; Al-Qudimat M; Hazin R; Alalami A; Jaradat I; Al-Husseini M; Abdeen G; Rodriguez-Galindo C; Qaddoumi I
    Int Ophthalmol; 2010 Aug; 30(4):407-14. PubMed ID: 20424888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
    Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma.
    Abramson DH; Beaverson KL; Chang ST; Dunkel IJ; McCormick B
    Arch Ophthalmol; 2004 Sep; 122(9):1316-23. PubMed ID: 15364710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of retinoblastoma with four-drug regimen including cisplatin, etoposide, vincristine, and cyclophosphamide.
    Varan A; Kiratli H; Aydın B; Tarlan B; Poyraz CB; Akyüz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2012 Sep; 29(6):529-37. PubMed ID: 22759219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.